276 related articles for article (PubMed ID: 29575277)
1. Association study of functional polymorphisms of dopaminergic pathway in epilepsy-related factors of temporal lobe epilepsy in Brazilian population.
Alcantara JA; Vincentis S; Kerr DS; Dos Santos B; Alessi R; van der Linden H; Chaim T; Serpa MH; Busatto GF; Gattaz WF; Demarque R; Valente KD
Eur J Neurol; 2018 Jun; 25(6):895-901. PubMed ID: 29575277
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.
Vereczkei A; Demetrovics Z; Szekely A; Sarkozy P; Antal P; Szilagyi A; Sasvari-Szekely M; Barta C
PLoS One; 2013; 8(6):e66592. PubMed ID: 23840506
[TBL] [Abstract][Full Text] [Related]
3. Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.
Kaminskaite M; Jokubka R; Janaviciute J; Lelyte I; Sinkariova L; Pranckeviciene A; Borutaite V; Bunevicius A
Gene; 2021 Jan; 765():145107. PubMed ID: 32889058
[TBL] [Abstract][Full Text] [Related]
4. Role of functional dopaminergic gene polymorphisms in the etiology of idiopathic intellectual disability.
Bhowmik AD; Chaudhury S; Dutta S; Shaw J; Chatterjee A; Choudhury A; Saha A; Sadhukhan D; Kar T; Sinha S; Mukhopadhyay K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1714-22. PubMed ID: 21609749
[TBL] [Abstract][Full Text] [Related]
5. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.
Nemoda Z; Lyons-Ruth K; Szekely A; Bertha E; Faludi G; Sasvari-Szekely M
Behav Brain Funct; 2010 Jan; 6():4. PubMed ID: 20205808
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
[TBL] [Abstract][Full Text] [Related]
7. Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features.
Gervasini G; Gordillo I; García-Herráiz A; Flores I; Jiménez M; Monge M; Carrillo JA
J Clin Psychopharmacol; 2013 Aug; 33(4):551-5. PubMed ID: 23775054
[TBL] [Abstract][Full Text] [Related]
8. No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder.
Heidinger BA; Cameron JD; Vaillancourt R; De Lisio M; Ngu M; Tasca GA; Chyurlia L; Doucet É; Doucette S; Maria Obregón Rivas A; Goldfield GS
Gene; 2021 May; 781():145538. PubMed ID: 33631245
[TBL] [Abstract][Full Text] [Related]
9. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
10. Differential associations of dopamine-related polymorphisms with discrete components of reaction time variability: relevance for attention deficit/hyperactivity disorder.
Grant P; Kuepper Y; Wielpuetz C; Hennig J
Neuropsychobiology; 2014; 69(4):220-6. PubMed ID: 24942140
[TBL] [Abstract][Full Text] [Related]
11. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans.
Treister R; Pud D; Ebstein RP; Laiba E; Gershon E; Haddad M; Eisenberg E
Pain; 2009 Dec; 147(1-3):187-93. PubMed ID: 19796878
[TBL] [Abstract][Full Text] [Related]
12. [The role of genetic variants of the dopaminergic system in heroin dependence].
Vereczkei A; Sasvári-Székely M; Barta C
Neuropsychopharmacol Hung; 2009 Jun; 11(2):95-101. PubMed ID: 19827317
[TBL] [Abstract][Full Text] [Related]
13. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3' UTR polymorphism of the dopamine transporter gene.
Tarnok Z; Ronai Z; Gervai J; Kereszturi E; Gadoros J; Sasvari-Szekely M; Nemoda Z
Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):900-5. PubMed ID: 17508355
[TBL] [Abstract][Full Text] [Related]
15. Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependence in a population from northeastern Brazil.
Vasconcelos AC; Neto Ede S; Pinto GR; Yoshioka FK; Motta FJ; Vasconcelos DF; Canalle R
Alcohol Clin Exp Res; 2015 Feb; 39(2):205-11. PubMed ID: 25684044
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.
Schacht JP; Voronin KE; Randall PK; Anton RF
Neuropsychopharmacology; 2018 May; 43(6):1247-1256. PubMed ID: 29362512
[TBL] [Abstract][Full Text] [Related]
17. Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): relationships to eating- and personality-related psychopathology.
Thaler L; Groleau P; Badawi G; Sycz L; Zeramdini N; Too A; Israel M; Joober R; Bruce KR; Steiger H
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):120-8. PubMed ID: 22683321
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms.
Srivastava V; Varma PG; Prasad S; Semwal P; Nimgaonkar VL; Lerer B; Deshpande SN; BK T
Pharmacogenet Genomics; 2006 Feb; 16(2):111-7. PubMed ID: 16424823
[TBL] [Abstract][Full Text] [Related]
19. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
[TBL] [Abstract][Full Text] [Related]
20. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.
Payton A; Holmes J; Barrett JH; Hever T; Fitzpatrick H; Trumper AL; Harrington R; McGuffin P; O'Donovan M; Owen M; Ollier W; Worthington J; Thapar A
Am J Med Genet; 2001 Jul; 105(5):464-70. PubMed ID: 11449400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
